PERISCOPE vs Navina
Navina is built for primary care and value-based groups with attributed populations. It summarizes charts, recommends HCCs at the visit and lists care gaps, with athenahealth, Epic and Veradigm named on the homepage. KLAS comments say some deployments use a Chrome extension, and one director reports that the EHR vendor does not love that. A VP calls its risk adjustment very good but focused on Medicare. Pricing is quote-only.
PERISCOPE is for a hospital's surgical quality team and follows post-operative patients, which puts it outside Navina's attributed primary care populations. It predicts postoperative bacterial infection from existing EHR data with XGBoost models built per hospital, and the vendor puts implementation at 8 to 12 weeks depending on the EHR. Testimonials come from Deventer Ziekenhuis and Amsterdam UMC.
Decision support · Reviewed November 2, 2026
When to pick each one
PERISCOPE
- Per-hospital XGBoost infection prediction from EHR data
- Implementation 8 to 12 weeks, vendor says
Navina
- Chart summaries and care-gap closure for value-based groups
- HIPAA, SOC 2 and ISO 27001 badges
Score
Each row shows points earned of points available under the published rubric.
PERISCOPE
15of 100
Navina
36of 100
| Dimension | PERISCOPE | Navina | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 10 / 10 | -10 |
| EHR integrations (count) | 0 / 5.6 | 1.7 / 5.6 | -1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 3.4 / 4.8 | -3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 8.4 / 21 | 0 / 21 | +8.4 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
PERISCOPE
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Navina
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
PERISCOPE
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
1 PubMed record names PERISCOPE.
Navina
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | PERISCOPE | Navina |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | athenahealth, Epic, Veradigm |
| Founded | n/a | 2018 |
| HQ | NL | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.


